Advertisement

Topics

American Cancer Society and Melanoma Research Alliance join forces to bring down immunotherapy side-effects

11:44 EDT 29 Jun 2017 | Pharmafile

The American Cancer Society (ACS) and the Melanoma Research Alliance (MRA) have formed a research partnership to reduce the impact of rare but serious side-effects as a result of checkpoint inhibitor drugs in the treatment of cancer by improving patient outcomes and minimising toxicity.

The two organisations have agreed to commit $1 million each to the joint grant-making programme; $1 million will be used to support one large research project, while $200,000 will be given each to five others, primarily focusing on melanoma, among other cancer types.

read more

Original Article: American Cancer Society and Melanoma Research Alliance join forces to bring down immunotherapy side-effects

NEXT ARTICLE

More From BioPortfolio on "American Cancer Society and Melanoma Research Alliance join forces to bring down immunotherapy side-effects"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Acute Coronary Syndromes ACS
Acute Coronary Syndromes (ACS) is an umbrella term for situations where the blood supplied to the heart muscle is suddenly blocked. Treatment for acute coronary syndrome includes medicines and a procedure known as angioplasty, during which doctors inflat...

Melanoma
Melanoma is a highly malignant tumor of melanin-forming cells (melanocytes) There are most commonly found in the skin (resulting from sunlight exposure), but also in the eyes and mucous membranes. Metastasis to other regions of the body is also common....